Xlife Sciences AG: Active pharmaceutical ingredient for pneumonia caused by COVID-19 (coronavirus)

Must Read

How To Block Your Bank Account And SIM Card In Case Of Emergency

Losing your phone and wallet or having them stolen can be very frustrating. However, in case that happens to...

List of First Bank of Nigeria Sort Codes in Nigeria

The sort code is a number that usually identifies both the bank and the branch where an account is held. The sort...

List of United Bank for Africa (UBA) Sort Codes & Branches (with addresses) in Nigeria

The sort code is a number that usually identifies both the bank and the branch where an account is held. The sort...
- Advertisement -

ZURICH, SWITZERLAND – EQS Newswire – March 11, 2020 – Xlife Sciences AG tests a new therapy for the treatment of pneumonia caused by coronavirus in cooperation with the Institute of Virology and Immunology (IVI) of the Vetsuisse Faculty of the University of Bern in Switzerland. Advantages of the therapy are a fundamentally better biovariability and a broad target diversity. The necessary documents have successfully been submitted.

The issuer is solely responsible for the content of this announcement.

About Xlife Sciences AG

Xlife Sciences AG (m:access: XLS) is a Swiss company with focus on investing in promising technologies in the life science industry. Xlife Sciences AG is building the bridge from research and development to healthcare markets. Together with industrial partners or universities, Xlife Sciences AG leads projects through the proof-of-concept phase after an invention disclosure or start-up. Subsequently, the firm focuses on out-licensing or selling the company, often with a combination of a strategic partnership. Xlife Sciences AG offers its investors direct access to the further development of innovative and future-oriented technologies at a very early stage.

For more information, please visit: www.xlifesciences.ch

Xlife Sciences AG: Active pharmaceutical ingredient for pneumonia caused by COVID-19 (coronavirus) - Brand Spur

- Advertisement -
Xlife Sciences AG: Active pharmaceutical ingredient for pneumonia caused by COVID-19 (coronavirus) - Brand SpurXlife Sciences AG: Active pharmaceutical ingredient for pneumonia caused by COVID-19 (coronavirus) - Brand Spur
- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Xlife Sciences AG: Active pharmaceutical ingredient for pneumonia caused by COVID-19 (coronavirus) - Brand SpurXlife Sciences AG: Active pharmaceutical ingredient for pneumonia caused by COVID-19 (coronavirus) - Brand Spur

Latest News

LafargeHolcim Proposes Reducing Company Name To Holcim

The world’s largest cement maker, LafargeHolcim is proposing to simplify its name to Holcim Limited, reverting to the name...
- Advertisement -
BrandsPur Weekly Cartoons
- Advertisement -Xlife Sciences AG: Active pharmaceutical ingredient for pneumonia caused by COVID-19 (coronavirus) - Brand SpurXlife Sciences AG: Active pharmaceutical ingredient for pneumonia caused by COVID-19 (coronavirus) - Brand Spur